OncoCyte Corporation (NASDAQ:OCX) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Tamika and I will be your conference operator today.
Oncocyte Corp (OCX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Broadwood Capital Neal C. Bradsher | 2,509,066 | $6,272,665 | 0.53% | |
| 2. | Pura Vida Investments Efrem Kamen | 586,930 | $1,467,325 | -11% | 0.22% |
| 3. | Renaissance Technologies Jim Simons | 12,718 | $32,000 | +5% | 0% |
| 4. | Millennium Management Israel Englander | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 0 | Large Shareholder | 4,929,066 | 2024-04-11 | Filing | |
| $2.92 | 2,420,000 | Large Shareholder | 4,929,066 | 2024-04-11 | Filing | |
| $2.95 | 3,390 | Officer, Director | 3,505 | 2024-04-11 | Filing | |
| $2.95 | 33,898 | Director | 69,054 | 2024-04-11 | Filing | |
| $0.21 | 30,000 | Director | 469,111 | 2023-06-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.03 | 40,464 | Large Shareholder | 8,479,682 | 2022-06-24 | Filing | |
| $1.05 | 12,517 | Large Shareholder | 8,520,146 | 2022-06-24 | Filing | |
| $1.03 | 35,441 | Large Shareholder | 7,427,202 | 2022-06-24 | Filing | |
| $1.05 | 10,964 | Large Shareholder | 7,462,643 | 2022-06-24 | Filing | |
| $1.14 | 8,128 | Officer | 16,872 | 2022-05-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 754,286 | $1,870,629 | 0.24% | |
| 2. | 247,873 | $619,683 | 0% | |
| 3. | 122,973 | $307,433 | 0% | |
| 4. | 71,650 | $179,125 | 0.06% | |
| 5. | 61,482 | $152,521 | 0% |
News See All
OncoCyte Corporation (NASDAQ:OCX) Q2 2023 Earnings Call Transcript
Operator: Welcome to the OncoCyte Q2 2023 Earnings Call. All participants will be in listen-only mode.
OncoCyte Corporation (NASDAQ:OCX) Q1 2023 Earnings Call Transcript
Operator: Good day. And welcome to the OncoCyte First Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode.
OncoCyte Corporation (NASDAQ:OCX) Q4 2022 Earnings Call Transcript
Operator: Good day and welcome to the OncoCyte Conference Call to discuss the Fourth Quarter and Year End 2022 Financial Results. Today's call is being recorded.
16 Best Penny Stocks to Buy Now
Investors are taking refuge in holding cash and liquidating their stock portfolios to weather out the impact of rising interest rates as the inflation rate is showing little signs of slowing down.
Hedge Fund and Insider Trading News: GoldenTree Asset Management, Tiger Global Management, Aperture Investors, LHG Capital Management, Fox Corp (FOX), Procter & Gamble Co (PG), and More
LHG Capital Management, a hedge fund firm focused on global macro investment strategies, received over US$600 million in net inflows in 2022.
These 5 Penny Stocks are Trending on Reddit
In this article, we take a look at the 5 penny stocks that are trending on Reddit.
5 Penny Stocks That Can Explode in 2022
Astra Space, Inc. (NASDAQ:ASTR) is a space launch company that deals in satellite launch services in the United States.
10 Pharmaceutical Stocks to Buy According to Efrem Kamen's Pura Vida Investments
In this article, we examined Efrem Kamen's portfolio management strategy and approach to investing in pharmaceutical stocks.
10 Best Biotech Stocks Under $6 in 2021
In this article we will take a look at the 10 best biotech stocks under $6 in 2021.
Billionaire Hedge Funds
